Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 054887/0144 | |
| Pages: | 26 |
| | Recorded: | 01/03/2021 | | |
Attorney Dkt #: | PAT058635-US-NP |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17025853
|
Filing Dt:
|
09/18/2020
|
Publication #:
|
|
Pub Dt:
|
06/10/2021
| | | | |
Title:
|
3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid and its salts formulation
|
|
Assignee
|
|
|
PLOT NO. 4, SURVEY NO'S 101 AND 101/2 |
LALGADI MALAKPET SHAMEERPET |
HYDERABAD, INDIA 500101 |
|
Correspondence name and address
|
|
NOVARTIS PHARMACEUTICALS CORPORATION
|
|
ONE HEALTH PLAZA
|
|
BUILDING 433
|
|
EAST HANOVER, NJ 07936
|
Search Results as of:
09/26/2024 07:03 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|